mobile menu
business
AU & NZ ENTERPRISE PROFILES

Noxopharm Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: NOX

What does Noxopharm Limited do?

Noxopharm Limited is a locally-owned, publicly-listed company, engaged in the development of Veyonda (idronoxil), an adjuvant drug for radiotherapy and chemotherapy in the treatment of late-stage cancers. The company operates in Australia and is administered by its head office in Chatswood, New South Wales.

Noxopharm Limited is listed on the Australian Securities Exchange under the code NOX.

 

Noxopharm Limited - Products & Brands

Noxopharm Limited is an Australia-based, ASX-listed company, engaged in the development of the Veyonda drug. The drug can:

  • Directly kill cancer cells
  • Work with the body's immune system to destroy tumours

The Company is trialling the new Veyonda product. It is currently not a registered treatment prescription medicine, however, it can be used (on compassionate grounds) for patients in Australia.

IBISWorld provides enterprise profiles on thousands of leading organizations across Australia and New Zealand.

LEARN MORE

Noxopharm Limited - Financial Statements

pie_chart Noxopharm Limited Financial Profit & Loss Account

BALANCE DATE6/30/20236/30/20226/30/20216/30/20206/30/2019
Sales Revenue00000
Other Revenue0000000000000000000000000
Total Revenue0000000000000000000000000
Cost of Goods Sold0000000000000000000000000
Depreciation0000000000000000000000000
R & D Expenditure0000000000000000000000000
lock To view Noxopharm Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Noxopharm Limited - Financial Ratios

pie_chart Noxopharm Limited Financial Growth

BALANCE DATE6/30/20236/30/20226/30/20216/30/20206/30/2019
Total Revenue Growth11.26-62.41-26.88406.06301.83
Sales Revenue Growth0000000000000000000000000
EBITDA0000000000000000000000000
NPAT0000000000000000000000000
Shareholder's Funds0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000

pie_chart Noxopharm Limited Financial Ratios

BALANCE DATE6/30/20236/30/20226/30/20216/30/20206/30/2019
Return on Revenue (ROR) (%)-247.1-340.9-64.2-1.4-285.0
Return on Shareholders’ Funds (ROSF) (%)0000000000000000000000000
Return on Assets (ROA) (%)0000000000000000000000000
Profit Margin (%)0000000000000000000000000
Revenue per Employee ($’000 per person)0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000
lock To view Noxopharm Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Noxopharm Limited's Competitive Environment

Noxopharm Limited operates in the following industries:

Noxopharm Limited's main competitors:

  • CSL Limited
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
lock To view Noxopharm Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Noxopharm Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Noxopharm Limited by position type and title.

Enterprise Financials

Get a full view of Noxopharm Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Noxopharm Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Noxopharm Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Noxopharm Limited operates in.

Competitor Benchmarking

Compare Noxopharm Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Noxopharm Limited.

Subsidiaries

View a list of Noxopharm Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Noxopharm Limited, including founding information, past announcements, mergers and major projects.

Purchase to Read Full Report

100% Money Back Guarantee Digicert Trusted

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Enterprise Financial Statements
  • Financial Ratios
    Financial Ratios
  • Industry Averages
    Industry Averages
  • Competitive Landscape
    Competitive Landscape
  • Key Enterprise Personnel
    Key Enterprise Personnel
  • Subsidiaries & Ownership Structure
    Subsidiaries & Ownership Structure

Why buy this enterprise profile on Noxopharm Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on Noxopharm Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal